These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 1435743)
1. Effect of extracellular pH on the potency of N-methyl-D-aspartic acid receptor competitive antagonists. Benveniste M; Mayer ML Mol Pharmacol; 1992 Oct; 42(4):679-86. PubMed ID: 1435743 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction. Benveniste M; Mayer ML Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203 [TBL] [Abstract][Full Text] [Related]
3. Potent, orally active, competitive N-methyl-D-aspartate (NMDA) receptor antagonists are substrates for a neutral amino acid uptake system in Chinese hamster ovary cells. Li JH; Bigge CF; Williamson RM; Borosky SA; Vartanian MG; Ortwine DF J Med Chem; 1995 May; 38(11):1955-65. PubMed ID: 7783127 [TBL] [Abstract][Full Text] [Related]
6. Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivo. Urwyler S; Campbell E; Fricker G; Jenner P; Lemaire M; McAllister KH; Neijt HC; Park CK; Perkins M; Rudin M; Sauter A; Smith L; Wiederhold KH; Müller W Neuropharmacology; 1996 Jun; 35(6):655-69. PubMed ID: 8887975 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacology of a series of 3- and 4-(phosphonoalkyl)pyridine- and -piperidine-2-carboxylic acids. Potent N-methyl-D-aspartate receptor antagonists. Ornstein PL; Schaus JM; Chambers JW; Huser DL; Leander JD; Wong DT; Paschal JW; Jones ND; Deeter JB J Med Chem; 1989 Apr; 32(4):827-33. PubMed ID: 2539478 [TBL] [Abstract][Full Text] [Related]
8. Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex. Clow DW; Lee SJ; Hammer RP Synapse; 1991 Apr; 7(4):260-8. PubMed ID: 1828310 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist. Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528 [TBL] [Abstract][Full Text] [Related]
10. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists. Lu Y; France CP; Woods JH J Pharmacol Exp Ther; 1992 Nov; 263(2):499-504. PubMed ID: 1432686 [TBL] [Abstract][Full Text] [Related]
11. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice. D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist. Bobelis DJ; Balster RL J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128 [TBL] [Abstract][Full Text] [Related]
13. Exploration of N-phosphonoalkyl-, N-phosphonoalkenyl-, and N-(phosphonoalkyl)phenyl-spaced alpha-amino acids as competitive N-methyl-D-aspartic acid antagonists. Bigge CF; Johnson G; Ortwine DF; Drummond JT; Retz DM; Brahce LJ; Coughenour LL; Marcoux FW; Probert AW J Med Chem; 1992 Apr; 35(8):1371-84. PubMed ID: 1533423 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of the N-methyl-D-aspartate receptor system coupled to the evoked release of gamma-[3H] aminobutyric acid from striatal neurons in primary culture. Weiss S J Pharmacol Exp Ther; 1990 Jan; 252(1):380-6. PubMed ID: 1967648 [TBL] [Abstract][Full Text] [Related]
16. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. Bakshi VP; Tricklebank M; Neijt HC; Lehmann-Masten V; Geyer MA J Pharmacol Exp Ther; 1999 Feb; 288(2):643-52. PubMed ID: 9918570 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. Feng B; Tse HW; Skifter DA; Morley R; Jane DE; Monaghan DT Br J Pharmacol; 2004 Feb; 141(3):508-16. PubMed ID: 14718249 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Wang T; French ED Synapse; 1993 Mar; 13(3):270-7. PubMed ID: 7684531 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. Williams K; Dichter MA; Molinoff PB Mol Pharmacol; 1992 Jul; 42(1):147-51. PubMed ID: 1353248 [TBL] [Abstract][Full Text] [Related]
20. Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists. Ornstein PL; Arnold MB; Lunn WH; Heinz LJ; Leander JD; Lodge D; Schoepp DD Bioorg Med Chem Lett; 1998 Feb; 8(4):389-94. PubMed ID: 9871691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]